...
【24h】

Evaluation of scoring systems in acute meningococcaemia.

机译:急性脑膜炎的评分系统评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Patients expected to develop life-threatening complications in acute meningococcal infections require early recognition and appropriate monitoring. Different prognostic scoring systems have been developed. Three of them, chosen according to their bedside availability, were compared with our clinical observations. Twenty consecutive cases of proven meningococcal infection were admitted to the paediatric intensive care unit (PICU) of the Free University of Brussels (AZ-VUB). Biological and clinical features required for prognostic scoring were evaluated as soon as possible after admission. Glasgow meningococcal sepsis prognostic score (GMSPS), Neisseria sepsis index (NESI) and Algren criteria were retrospectively calculated and evaluated for their prognostic significance. Neisseria meningitidis was cultured from blood and cerebrospinal fluid in 11 patients and from blood in only nine patients. The age of the patients was between 1 and 15 years (mean 4.1 years). All patients received the same therapy on admission. Four patients died with a multiorgan failure within 18 hours. The three scoring systems in these four patients predicted death. Overall, the GMSPS score, the NESI score and the Algren criteria predicted death in respectively 10, nine and five patients. Death was falsely predicted in six patients by the GMSPS score, in five patients by the NESI score and in one patient by the Algren criteria. The Algren criteria predicted the severity of the clinical process more accurately than did the GMSPS and NESI scores. However, such predictability should be cautiously used even when 100% mortality is predicted. It might be used in decision-making in regard to the following issues: patient transfer to tertiary centres and mode of transportation, monitoring of patients in intensive care units, early insertion of invasive cardiovascular monitoring catheters and consideration of new or even experimental therapy. However, one should be extremely cautious of taking any therapeutically or ethical decision on the basis of one or more of the described scoring system, since we showed the lack of precision concerning the outcome of paediatric patients with meningococcaemia.
机译:预期在急性脑膜炎球菌感染中会危及生命的并发症的患者需要尽早识别并进行适当监测。已经开发了不同的预后评分系统。根据他们在床边的可用性选择了其中的三个,并与我们的临床观察结果进行了比较。连续二十例证实的脑膜炎球菌感染病例被布鲁塞尔自由大学的小儿重症监护病房(PICU)录取。入院后尽快评估预后评分所需的生物学和临床特征。回顾性计算格拉斯哥脑膜炎球菌败血症的预后评分(GMSPS),奈瑟菌败血症指数(NESI)和Algren标准,并评估其预后意义。脑膜炎奈瑟氏球菌是从11名患者的血液和脑脊液中培养的,只有9名患者是从血液中培养的。患者的年龄为1至15岁(平均4.1岁)。所有患者入院时均接受相同的治疗。四名患者在18小时内死于多器官功能衰竭。这四名患者的三个评分系统可预测死亡。总体而言,GMSPS评分,NESI评分和Algren标准分别预测了10例,9例和5例患者的死亡。 GMSPS评分错误地预测了六名患者的死亡,NESI评分错误地预测了五名患者,Algren标准错误地预测了一名患者。 Algren标准比GMSPS和NESI分数更准确地预测了临床过程的严重性。但是,即使预测死亡率为100%,也应谨慎使用这种可预测性。它可用于以下方面的决策:将患者转移到三级中心和运输方式,对重症监护室中的患者进行监测,及早插入有创心血管监测导管以及考虑采用新的甚至实验性疗法。但是,由于我们对小儿脑膜炎双球菌血症患者的治疗结果缺乏精确性,因此,在根据所述评分系统中的一项或多项做出任何治疗或伦理决定时,应当格外谨慎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号